This trial will explore whether exercise can help protect the hearts of breast cancer patients receiving chemotherapy that is known to damage heart health.
1 Primary · 5 Secondary · Reporting Duration: Outcome will be assessed at baseline (week 0), post-intervention (week-13) and 6 months after the completion of the intervention.
Active Control
Experimental Treatment
100 Total Participants · 2 Treatment Groups
Primary Treatment: Aerobic exercise · No Placebo Group · N/A
Age 18+ · Female Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Met criteria | 100.0% |